Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Andrea R. Mospan"'
Autor:
A. Sidney Barritt, Stephanie Watkins, Norman Gitlin, Samuel Klein, Anna S. Lok, Rohit Loomba, Cheryl Schoen, K. Rajender Reddy, Huy Ngoc Trinh, Andrea R. Mospan, Miriam B. Vos, L. Michael Weiss, Kenneth Cusi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal
Publikováno v:
Hepatology Communications, Vol 5, Iss 6, Pp 938-946 (2021)
Much of the current data on nonalcoholic fatty liver disease (NAFLD) are derived from biopsy‐based studies that may introduce ascertainment and selection bias. Selection of patients for liver biopsy has implications for clinical practice and the re
Externí odkaz:
https://doaj.org/article/cd7644ce825744c5998578481955510e
Autor:
Roniel Cabrera, Amit G. Singal, Massimo Colombo, R. Kate Kelley, Hannah Lee, Andrea R. Mospan, Tim Meyer, Pippa Newell, Neehar D. Parikh, Bruno Sangro, K. Rajender Reddy, Stephanie Watkins, Richard C. Zink, Adrian M. Di Bisceglie
Publikováno v:
Hepatology Communications, Vol 5, Iss 3, Pp 538-547 (2021)
This study describes the design of the TARGET‐hepatocellular carcinoma (HCC) cohort and descriptive characteristics of the patient population at diagnosis among those who were enrolled in the cohort across academic and community clinical centers. T
Externí odkaz:
https://doaj.org/article/9b84ea20c906414cb172f617c7c11105
Autor:
Eduardo Castillo-Leon, Heather L. Morris, Cheryl Schoen, Jacob Bilhartz, Patrick McKiernan, Tamir Miloh, Sirish Palle, Mohammad Nasser Kabbany, Breda Munoz, Andrea R. Mospan, Bryan Rudolph, Stavra A. Xanthakos, Miriam B. Vos, TARGET-NASH Investigators
Publikováno v:
Children, Vol 9, Iss 3, p 374 (2022)
Background: Pediatric non-alcoholic fatty liver disease (NAFLD) is a major public health concern. Aminotransferase (ALT) is frequently used for screening and monitoring, but few studies have reported typical patterns of ALT elevation in children. Met
Externí odkaz:
https://doaj.org/article/0f083155b0ed468a8ca62e5e05569e87
Autor:
Arun J. Sanyal, Breda Munoz, Kenneth Cusi, A. Sidney Barritt, Mark Muthiah, Andrea R. Mospan, K. Rajender Reddy, Roberto Firpi-Morell, Paul J. Thuluvath, Kalyan Ram Bhamidimarri, Michael W. Fried, Manal Abdelmalek, Humberto Aguilar, Aijaz Ahmed, Alina Allen, Sarah Barlow, Sid Barritt, David Bernstein, Kaylan Bhamidimarri, Liana Billings, Kyle Brown, Robert Brown, Karen Corbin, Andrew deLemos, Karan Emerick, Maged Adel Ghali, Zachary Henry, Whitney Jackson, Sujit Janardhan, Mohammad Kabbany, Nyingi Kemmer, David Koch, Justin Kupec, Charles Landis, Mary Katherine Lawrence, Cynthia Levy, Steven Lidofsky, Anna Lok, Velimir Luketic, Enrique Martinez, Craig McClain, Patrick McKiernan, Ellen Mitchell, Mazen Noureddin, Sirish Palle, Yen Pham, David Pound, Rajender Reddy, Fredric Regenstein, Mary Rinella, Fedja Rochling, Bryan Rudolph, Vinod Rustgi, Adnan Said, Niharika Samala, Souvik Sarkar, Kenneth Sherman, Mitchell Shiffman, Coleman Smith, Jawahar Taunk, Brent Tetri, Paul Thuluvath, Huy Trinh, Elizabeth Verna, Miriam Vos, L. Michael Weiss, Mark Wong, Kathleen Wyne, Stavra Xanthakos
Publikováno v:
Clinical Gastroenterology and Hepatology.
Autor:
Jawahar L. Taunk, Anna S. Lok, Andrea R. Mospan, Hannah P. Kim, Paul J. Thuluvath, Philip N. Newsome, Michael W. Fried, Michael Roden, Arun J. Sanyal, Michael O. Idowu, A. Sidney Barritt, Andrew G. Allmon
Publikováno v:
Alimentary Pharmacology & Therapeutics. 54:1472-1480
Background Patients with non-alcoholic steatohepatitis (NASH) and fibrosis stage ≥2 comprise a target population for pharmacotherapy. Liver biopsy, the reference standard for identifying this population, requires complete and accurate assessment of
Publikováno v:
Liver International. 41:61-67
Real-world evidence includes all health-related information, such as electronic health records, insurance claims, pharmacy records and wearables that are obtained outside of clinical trials. These data can provide critical insights into the natural h
Autor:
Michael W. Fried, Eugene R. Schiff, David E. Bernstein, Huy N. Trinh, Richard C. Zink, Andrea R. Mospan, Coleman Smith, Anna S. Lok
Publikováno v:
Digestive Diseases and Sciences. 67:2637-2645
Nucleos(t)ide analogues, with a proven record of safety and efficacy, have been the therapy of choice for over a decade for the treatment of chronic hepatitis B. The approval of tenofovir alafenamide (TAF) in 2016 provided an additional treatment opt
Autor:
Julie M. Crawford, Robert S. Brown, K. Rajender Reddy, Andrea R. Mospan, Elizabeth C. Verna, Michael W. Fried, Janet S. Hildebrand, Breda Munoz, Charles S. Landis, Heather L Morris
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Patients hospitalized for coronavirus disease 2019 (COVID-19) may experience complications following hospitalization and require readmission. In this analysis, we estimated the rate and risk factors associated with COVID-19–related readm
Autor:
Arun J. Sanyal, Miriam B. Vos, Cheryl Schoen, L. Michael Weiss, Norman Gitlin, Andrea R. Mospan, Samuel Klein, Rohit Loomba, Kenneth Cusi, Huy N. Trinh, K. Rajender Reddy, Brent A. Neuschwander-Tetri, Stephanie Watkins, Anna S. Lok, A. Sidney Barritt
Publikováno v:
Hepatology Communications, Vol 5, Iss 6, Pp 938-946 (2021)
Hepatology Communications
Hepatology Communications
Much of the current data on nonalcoholic fatty liver disease (NAFLD) are derived from biopsy‐based studies that may introduce ascertainment and selection bias. Selection of patients for liver biopsy has implications for clinical practice and the re
Autor:
Adrian M. Di Bisceglie, Bruno Sangro, Andrea R. Mospan, Stephanie Watkins, Hannah Lee, Richard C. Zink, Pippa Newell, Neehar D. Parikh, Roniel Cabrera, R. Kate Kelley, Amit G. Singal, K. Rajender Reddy, Massimo Colombo, Tim Meyer
Publikováno v:
Hepatology Communications
Hepatol Commun
Hepatology Communications, Vol 5, Iss 3, Pp 538-547 (2021)
Hepatol Commun
Hepatology Communications, Vol 5, Iss 3, Pp 538-547 (2021)
This study describes the design of the TARGET‐hepatocellular carcinoma (HCC) cohort and descriptive characteristics of the patient population at diagnosis among those who were enrolled in the cohort across academic and community clinical centers. T